Psoriasis inversa is a special form of psoriasis that mainly occurs in skin folds and flexor regions. In contrast to classic psoriasis vulgaris, which is mainly localized on the extensor sides of the joints, the inverse form prefers to affect the armpits, groin, the area under the breasts, the gluteal fold and the genital and anal area. Around three to seven percent of all psoriasis patients suffer from this form. As with other forms of psoriasis, the cause is a genetic predisposition in combination with trigger factors such as infections, stress, certain medications or mechanical irritation. In the case of psoriasis inversa, moisture, heat and friction in the skin folds exacerbate the symptoms. The appearance differs significantly from classic psoriasis: the skin shows sharply defined, shiny, deep red to purple plaques without the typical silvery scaling, as the moisture in the skin folds prevents the formation of scales. The skin may ooze and is often macerated. Diagnosis can be difficult as the appearance is atypical and can easily be confused with fungal infections, intertrigo or other skin conditions. A skin biopsy can confirm the diagnosis. Treatment is challenging as the affected areas are sensitive and sweat profusely. Topical corticosteroids must be dosed carefully as the skin in skin folds absorbs active ingredients more readily. Calcineurin inhibitors such as tacrolimus or pimecrolimus are well tolerated. It is important to keep the skin folds dry, wear airy clothing and reduce excess weight. In severe cases, systemic therapies such as biologics may be necessary. As with other forms of psoriasis, the prognosis is chronic, but can be well controlled with good therapy.
December 24, 2024, to December 27, 2024: No dermatology consultations or aesthetic treatments.
December 23, 2024, December 30, 2024, and December 31, 2024: Dermatology consultations available.
December 24, 2024, December 27, 2024, and December 28, 2024: Cosmetic treatments available.
December 20, 2024, and December 31, 2024: Cosmetic treatments available.
January 1, 2025, to January 2, 2025: No cosmetic treatments or dermatology consultations.